New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Following the lead of other states, New York racing officials have formed an advisory panel to bolster efforts to track new developments in legal and illegal drugs used in the thoroughbred industry. "There's no agenda going into this,'' said Racing and Wagering Board chairman Michael Hoblock, who announced the creation of the Medication Advisory Committee Thursday. He said the idea of such a panel came out of meetings over the past several years the racing board has held with the New York Racing Association's organization of horsemen.
Most Popular Stories
- Akeed Mofeed Takes HK Cup; Little Mike 9th
- New Career Plans for Retired Comma to the Top
- Dozen Pointed for $750,000 CashCall Futurity
- Glorious Days Closes to Win Hong Kong Mile
- Dominant Upsets The Fugue in Hong Kong Vase
- Lord Kanaloa Impresses in Career Finale
- Red Reveur Upsets Hanshin Juvenile Fillies
- Streaming Surges Clear for Starlet Surprise
- Apprentice Jockey Vanessa Fry Wins Her First
- Multiple Grade I Winner Flat Out Retired